Final report of the lyme disease review panel of the infectious diseases society of America

Clinical Infectious Diseases

Volumn 51, Issue 1, 2010, Pages 1-5

  Lantos, Paul M ^a   Charini, William A ^b   Medoff, Gerald ^c   Moro, Manuel H ^d   Mushatt, David M ^e   Personnet, Jeffrey ^f   Sanders, John W ^h   Baker, Carol J ^g  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Lawrence General Hospital   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h California   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

BACTERIAL ENDOCARDITIS; CLINICAL DECISION MAKING; CONFLICT OF INTEREST; CONSENSUS DEVELOPMENT; DATA ANALYSIS; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; HUMAN; INFECTION COMPLICATION; LONG TERM CARE; LYME DISEASE; MEDICAL SOCIETY; OSTEOMYELITIS; POSTLYME DISEASE SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; TICK BORNE DISEASE; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTITRUST LAWS; CONFLICT OF INTEREST; CONNECTICUT; DRUG ADMINISTRATION SCHEDULE; HEALTH POLICY; HUMANS; LYME DISEASE; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; UNITED STATES;

EID: 77953803603     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/654809     Document Type: Review

References (14)

1. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1089-1134.
2. Connecticut Office of the Attorney General and the Infectious Diseases Society of America. An agreement between the Attorney General of the State of Connecticut and the Infectious Diseases Society of America. 2008. http://www.ct.gov/ag/lib/ag/health/idsaagreement.pdf. Accessed 22 April 2010.
3. Cameron D, Gaito A, Harris N, et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther 2004; 2:S1-13.
4. Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007;69:91-102. (Pubitemid 47025211)
5. Mygland A, Ljostad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Neurology 2008;70(13):992-1003.
6. Brouqui F, Bacellar F, Baranton G, et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect 2004; 10:1108-1132. (Pubitemid 40050854)
7. American College of Physicians. Guidelines for laboratory evaluation in the diagnosis of'Lyme disease. Ann Intern Med 1997; 127:1106-1108.
8. Wormser GP, Nadelman RB, Dattwyler RJ, et al; The Infectious Diseases Society of America. Practice guidelines for the treatment of Lyme disease. Clin Infect Dis 2000;31(suppl 1):1-14.
9. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008;70:992-1003.
10. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85-92. (Pubitemid 32634566)
11. Krupp LB, Hyman LG, Crimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003;60:1923-1930.
12. Oksi J, Nikoskelainen J, Hiekkanen H, et al. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 2007;26:571-581. (Pubitemid 47106811)
13. Kaplan RF, Trevino RP, Johnson GM, et al. Cognitive function in posttreatment Lyme disease: do additional antibiotics help? Neurology 2003; 60:1.916-1922.
14. Strieker RB, Green CL, Savely VR, et al. Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Minerva Med 2010; 101:1-7.